Adial pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Adial pharmaceuticals Contact Number

Adial Pharmaceuticals, Inc. 1180 Seminole Trail, Ste 495 Charlottesville, VA 22901. Email: [email protected] Phone: (434) 422-9800

Contact US: https://www.adialpharma.com/contact/

What is adial pharmaceuticals?

This opens in a new window. Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is currently in Phase 3 development as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD).

What s the strategy of adial to treat ad04?

Adial’s strategy is to integrate pre-treatment genetic screening into AD04’s label to create a patient-specific treatment in one integrated therapeutic offering. Adial’s goal is to develop a genetically targeted, effective and safe product candidate to treat AUD that does not require abstinence as part of the treatment.

What is ad04 drug?

The Company’s lead investigational new drug product, AD04, is currently in Phase 3 development as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD).

Is there a clinical trial for ad04 for aud?

Adial has commenced a Phase 3 clinical trial using AD04 for the potential treatment of AUD in subjects with certain target genotypes.

Adil)

70 People Used

See More ››

Adial Pharmaceuticals (nasdaq: Adil)

Contact Number View Number; Human Resources (HR) HR Head and director: Adial Pharmaceuticals (nasdaq: Adil) [email protected] ****322*** View Number: CEO: Chief Executive Officer: Adial Pharmaceuticals (nasdaq: Adil) [email protected] ****461*** View Number: Founder and Cofounder: Founder: Adial Pharmaceuticals (nasdaq: Adil) xxxx

View Contact ››

Treatment

31 People Used

See More ››

Adial Pharmaceuticals Inc. Medicines for Addiction

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the treatment and prevention of addictions. The Company’s lead investigational new drug product, AD04, is currently in Phase 3 development as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD).

View Contact ››

Contact

65 People Used

See More ››

Adial Pharmaceuticals

Contact Email [email protected] Phone Number 434-422-9800 Adial Pharmaceuticals, LLC engages in the development of prescription medications for …

View Contact ››

Pharma

74 People Used

See More ››

ADial Pharmaceuticals, LLC Pharmaceutical.Report

north america leads in number of global pharma partnerships Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019. According to new research, North America the highest amount of strategic pharma partnerships in the global pharmaceutical industry from 2014 to the first half of 2019.

View Contact ››

Adial

75 People Used

See More ››

EIN 80 0667150

Adial Pharmaceuticals, Inc. is a corporation in Charlottesville, Virginia. The employer identification number (EIN) for Adial Pharmaceuticals, Inc. is 800667150. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

View Contact ››

Stores

61 People Used

See More ››

Adial Pharmaceuticals Inc

Business Overview "Adial Pharmaceuticals Inc" of Charlottesville, VA 22901 operates primarily in SIC Code 5912 - Drug Stores and Proprietary Stores and NAICS Code 446110 - Pharmacies and Drug Stores.Adial Pharmaceuticals Inc is a small-sized business with medium revenue, that …

View Contact ››

M&A

53 People Used

See More ››

Adial Pharmaceuticals Inc. MANAGEMENT

William B. Stilley has served as our Chief Executive Officer since co-founding the company in December 2010. Prior to joining Adial Pharmaceuticals, he was the Vice President, Business Development & Strategic Projects at Clinical Data, Inc. (NASDQ CLDA), where he worked on licensing and M&A transactions and was involved in management of Phase 3 clinical trials, production of Viibryd ® for

View Contact ››

Natalya

196 People Used

See More ››

ADIAL PHARMACEUTICALS, INC. (Form: 8 K, Received: 02/01

Adial Pharmaceuticals, Inc. (Exact name of registrant as specified in charter) the number of membership interests in the Company to be sold to Purchaser by the Member Contact: Crescendo Communications, LLC. David Waldman / Natalya Rudman. Tel: 212-671-1021.

View Contact ››

(908)

41 People Used

See More ››

Let''s Connect

Administrative Offices: U.S. Corporate Offices. 400 Crossing Boulevard, 3rd Floor Bridgewater, New Jersey 08807 Phone: (908) 947-3120 Fax: (908) 947-3146

View Contact ››

Investor

38 People Used

See More ››

Adial Pharmaceutical, Inc. (ADIL)

Investor Contact Information. Company. Adial Pharmaceutical, Inc. 1180 Seminole Trail Ste 495 Charlottesville, VA 22901 [email protected] Investor Relations. Crescendo Communications, LLC David Waldman 5 Penn Plaza Suite 1953 New York, NY …

View Contact ››

Please leave your comments here:

Popular Brands

Amazon
Asml
Abbvie
Apple
Acc
Att
Amd
Abb
Aak
Agco